A novel TTC7A deficiency presenting with combined immunodeficiency and chronic gastrointestinal problems

Sharafian, S; Alimadadi, H; Shahrooei, M; Gharagozlou, M; Aghamohammadi, A; Parvaneh, N.
J. investig. allergol. clin. immunol ; 28(5): 358-360, 2018.
Artículo en Inglés | IBECS (España) | ID: ibc-174547

Documentos relacionados

  1. Existe-t-il un risque accru d'évènement cardiovasculaire immédiatement après une poussée de goutte ?
  2. Detecting symptom exaggeration and minimization using translated versions of the MMPI-2 and MMPI-2-RF: A systematic review and preliminary meta-analysis.
  3. Investigating gout flares: beyond a definition.
  4. Flare in Systemic Lupus Erythematosus: Lost in Translation?
  5. Upregulated expression of FFAR2 and SOC3 genes is associated with gout.
  6. Activation Status of NLRP3 Inflammasome in Peripheral Blood Mononuclear Cells From Patients With Gout Flare.
  7. [Clinical characteristics and genetic analysis of a Chinese pedigree affected by glycogen storage disease type Ia with gout as the first manifestation].
  8. Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.
  9. Ultrasonography in the prediction of gout flares: a 12-month prospective observational study.
  10. Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study.